A microRNA signature panel predicts differential sensitivity of liver cancer cells to chemotherapeutic drugs

被引：0
|
作者：
Tryndyak, Volodymyr [1 ]
Kindrat, Iryna [1 ]
McDannell, Brigit [2 ]
Beland, Frederick A. [1 ]
Pogribny, Igor P. [1 ]
机构：
[1] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
[2] Smith Coll, Northampton, MA 01063 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-5887
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5887
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Prehepatectomy Circulating Exosomal microRNA Signature Predicts the Prognosis and Adjuvant Chemotherapeutic Benefits in Colorectal Liver Metastasis
    Wang, Yun
    Chen, Xiuxing
    Lin, Haocheng
    Sun, Xiaoqiang
    Fong, William Pat
    Wu, Xiaojun
    Pan, Zhizhong
    Yuan, Yunfei
    Liang, Jieying
    Wang, Deshen
    Du, Ziming
    Xing, Baocai
    Li, Yuhong
    CANCERS, 2021, 13 (17)
  • [2] MicroRNA signature in liver cancer
    Ghafouri-Fard, Soudeh
    Tamizkar, Kasra Honarmand
    Hussen, Bashdar Mahmud
    Taheri, Mohammad
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 219
  • [3] A panel of microRNA signature in serum for colorectal cancer diagnosis
    Zhu, Mingxia
    Huang, Zebo
    Zhu, Danxia
    Zhou, Xin
    Shan, Xia
    Qi, Lian-Wen
    Wu, Lirong
    Cheng, Wenfang
    Zhu, Jun
    Zhang, Lan
    Zhang, Huo
    Chen, Yan
    Zhu, Wei
    Wang, Tongshan
    Liu, Ping
    ONCOTARGET, 2017, 8 (10) : 17081 - 17091
  • [4] MicroRNA signature predicts survival and relapse in lung cancer
    Yu, Sung-Liang
    Chen, Hsuan-Yu
    Chang, Gee-Chen
    Chen, Chih-Yi
    Chen, Huei-Wen
    Singh, Sher
    Cheng, Chiou-Ling
    Yu, Chong-Jen
    Lee, Yung-Chie
    Chen, Han-Shiang
    Su, Te-Jen
    Chiang, Ching-Cheng
    Li, Han-Ni
    Hong, Qi-Sheng
    Su, Hsin-Yuan
    Chen, Chun-Chieh
    Chen, Wan-Jiun
    Liu, Chun-Chi
    Chan, Wing-Kai
    Chen, Wei J.
    Li, Ker-Chau
    Chen, Jeremy J. W.
    Yang, Pan-Chyr
    CANCER CELL, 2008, 13 (01) : 48 - 57
  • [5] Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators
    Geretto, Marta
    Pulliero, Alessandra
    Rosano, Camillo
    Zhabayeva, Dinara
    Bersimbaev, Rakhmet
    Izzotti, Alberto
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (06): : 1350 - 1371
  • [6] Microrna expression signature predicts lung cancer diagnosis and prognosis
    Carlo, M.
    Croce, M. D.
    ANNALS OF ONCOLOGY, 2006, 17 : VII156 - VII156
  • [7] Effects of Chemotherapeutic Drugs in Colorectal Cancer Cells
    Tristante-Barrenechea, E.
    Mayor-Lopez, L.
    Lujan, J.
    De Torre, C.
    Carbonell, P.
    Martinez-Marin, R.
    Torroba, A.
    Bermejo, J.
    Carballo, F.
    Martinez-Lacaci, I.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S232 - S232
  • [8] DNA demethylation increases sensitivity of neuroblastoma cells to chemotherapeutic drugs
    Charlet, Jessica
    Schnekenburger, Michael
    Brown, Keith W.
    Diederich, Marc
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (07) : 858 - 865
  • [9] Inhibition of the MAPK pathways enhances the sensitivity of triple negative breast cancer cells to chemotherapeutic drugs
    Bhatt, Akshita B.
    Wright, Thomas D.
    Patel, Saloni
    Chakrabarty, Suravi
    Barnes, Van
    Burow, Matthew
    Burow, Matthew
    Flaherty, Patrick T.
    Cavanaugh, Jane
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [10] Inactivation of ID-1 gene induces sensitivity of prostate cancer cells to chemotherapeutic drugs
    Wong, Yong-Chuan
    Zhang, Xiao-Meng
    Ling, Ming-Tak
    Wang, Xiang-Hong
    HORMONAL CARCINOGENESIS V, 2008, 617 : 565 - 572
12345